- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | FDA Grants Priority Review To Syndax's Revuforj For R/R MNPM1 Acute Myeloid Leukemia Treatment | ||
| Mi | Ladder Capital Prices Public Offering Of $500 Mln Of 5.500% Senior Notes Due 2030 | ||
| Mi | TELUS Prices Offering Of US$1.5 Bln Of Fixed-to-Fixed Rate Junior Subordinated Notes | ||
| Di | BlackBerry Q1 Earnings Summary | ||
| Di | AEROVIRONMENT INC Reports Rise In Q4 Profit | ||
| Di | AZEK Divests Scranton Products Division To Sky Island Capital For Strategic Growth | ||
| Di | Candel Therapeutics Announces $15 Mln Direct Offering To Fund CAN-2409 Launch Readiness | ||
| Di | Houston American Energy Announces $1.2 Mln Registered Direct Offering At $14.80 A Share | ||
| Di | Amarin Shares Surge 34% On European Licensing Deal With Recordati | ||
| Di | GeneDx Shares Rise Over 12% On AAP Endorsement Of Genomic Testing For Children | ||
| Di | Kratos Defense Shares Slide Over 6% | ||
| Di | Hoth Therapeutics' Topical Gel Shows Promise In Mitigating Cancer Treatment Related Skin Problems | ||
| Di | Rezolve Ai Achieves $70 Mln ARR, Secures Microsoft And Google Deals, Joins Russell 2000 | ||
| Di | McDonalds And Krispy Kreme To End Doughnut Partnership In July 2025 | ||
| Di | IQSTEL Reports 5-month Preliminary Revenue Of $101.5 Mln; Confirms Annual Revenue Outlook | ||
| Di | Why Veru Inc. Is Rising In Pre-market? | ||
| Di | SINTX Technologies Acquires Surgical Business Assets Of SiNAPTIC Holdings | ||
| Di | TD SYNNEX Corporation Q2 Profit Increases, Beats Estimates | ||
| Di | BriaCell Says Independent DSMB Raised No Safety Concerns Of Phase 3 Study Of Bria-IMT Plus CPI | ||
| Di | Royalty Pharma Enters Into Upto $2 Bln Funding Deals With Revolution Medicines | ||
| Di | Immunic Posts Positive Long-Term OLE Data From Phase 2 Trial Of Vidofludimus Calcium In RRMS | ||
| Di | Fortrea Enters Strategic Collaboration With Emery Pharma | ||
| Di | CytoSorbents Files Request For Supervisory Review For DrugSorb-ATR Device | ||
| Di | Revolution Medicines Partners Royalty Pharma On $2 Bln Flexible Funding | ||
| Di | AstroNova Urges Shareholders To Vote For Its Six Director Nominees |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .